Australia markets closed

BARD1 Life Sciences Limited (BD1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0310-0.0010 (-3.13%)
At close: 3:52PM AEST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
Total revenue
-
-
62.418
44.028
Gross profit
-
-
62.418
44.028
Operating expenses
Research development
612.406
576.738
770.842
1,090
Selling general and administrative
1,881
1,214
905.213
1,302
Total operating expenses
3,005
2,302
2,104
2,597
Operating income or loss
-3,005
-2,302
-2,104
-2,597
Total other income/expenses net
557.538
576.236
313.109
-11.87
Income before tax
-2,395
-1,717
-1,784
-2,604
Income tax expense
0
0
0
0
Income from continuing operations
-2,395
-1,717
-1,784
-2,604
Net income
-2,395
-1,717
-1,784
-2,604
Net income available to common shareholders
-2,395
-1,717
-1,784
-2,604
Basic EPS
-
-0.00
-0.00
-0.00
Diluted EPS
-
-0.00
-0.00
-0.00
Basic average shares
-
1,265,912
717,142
569,184
Diluted average shares
-
1,265,912
717,142
569,184
EBITDA
-
-2,302
-2,104
-2,588